Miller DS - Search Results

1

Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.

Lea JS, Sheets EE, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Feb;84(2):285-8. doi: 10.1006/gyno.2001.6524. Gynecol Oncol. 2002. PMID: 11812088

2

The effect of naproxen on fever in patients with advanced gynecologic malignancies.

Economos K, Lucci JA 3rd, Richardson B, Yazigi R, Miller DS. Economos K, et al. Among authors: miller ds. Gynecol Oncol. 1995 Feb;56(2):250-4. doi: 10.1006/gyno.1995.1041. Gynecol Oncol. 1995. PMID: 7534741 Clinical Trial.

3

DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.

Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR. Coleman RL, et al. Among authors: miller ds. Gynecol Oncol. 1993 Jul;50(1):20-4. doi: 10.1006/gyno.1993.1157. Gynecol Oncol. 1993. PMID: 8349159

4

Preinvasive and invasive breast and cervical cancer prior to or during pregnancy.

Shivvers SA, Miller DS. Shivvers SA, et al. Among authors: miller ds. Clin Perinatol. 1997 Jun;24(2):369-89. Clin Perinatol. 1997. PMID: 9209808 Review.

5

In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer.

von Gruenigen VE, Santoso JT, Coleman RL, Muller CY, Miller DS, Mathis JM. von Gruenigen VE, et al. Among authors: miller ds. Gynecol Oncol. 1998 Jun;69(3):197-204. doi: 10.1006/gyno.1998.5010. Gynecol Oncol. 1998. PMID: 9648587

6

Does glutamine supplementation increase radioresistance in squamous cell carcinoma of the cervix?

Santoso JT, Lucci JA 3rd, Coleman RL, Hatch S, Wong P, Miller D, Mathis JM. Santoso JT, et al. Gynecol Oncol. 1998 Dec;71(3):359-63. doi: 10.1006/gyno.1998.5175. Gynecol Oncol. 1998. PMID: 9887231

7

Role of TSG101 in uterine cervix cancer.

O'Boyle JD, Proctor ML, Fong KM, Lin WM, Miller DS, Muller CY. O'Boyle JD, et al. Among authors: miller ds. Gynecol Oncol. 1999 Dec;75(3):401-5. doi: 10.1006/gyno.1999.5612. Gynecol Oncol. 1999. PMID: 10600297

8

Uterine metastasis from a heterologous metaplastic breast carcinoma simulating a primary uterine malignancy.

Sinkre P, Milchgrub S, Miller DS, Albores-Saavedra J, Hameed A. Sinkre P, et al. Among authors: miller ds. Gynecol Oncol. 2000 Apr;77(1):216-8. doi: 10.1006/gyno.1999.5712. Gynecol Oncol. 2000. PMID: 10739717

9

Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.

Miller DS, Blessing JA, Kilgore LC, Mannel R, Van Le L. Miller DS, et al. Am J Clin Oncol. 2000 Aug;23(4):355-7. doi: 10.1097/00000421-200008000-00009. Am J Clin Oncol. 2000. PMID: 10955863 Clinical Trial.

10

Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants.

Sherwood JB, Shivapurkar N, Lin WM, Ashfaq R, Miller DS, Gazdar AF, Muller CY. Sherwood JB, et al. Among authors: miller ds. Gynecol Oncol. 2000 Oct;79(1):90-6. doi: 10.1006/gyno.2000.5922. Gynecol Oncol. 2000. PMID: 11006038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters